Valuation: Clover Corporation Limited

Market Cap 142M 99.15M 86.65M 79.96M 73.7M 139M 9.55B 956M 376M 4.68B 372M 364M 16.1B P/E 2026 *
14.6x
P/E 2027 * 10.6x
Enterprise Value 140M 97.54M 85.24M 78.66M 72.51M 137M 9.39B 940M 370M 4.6B 366M 358M 15.84B EV / Sales 2026 *
1.49x
EV / Sales 2027 * 1.16x
Free-Float
76.93%
Yield 2026 *
-
Yield 2027 * -
1 day+0.59%
1 week+13.25%
Current month+1.18%
1 month-3.93%
3 months-13.20%
6 months+6.88%
Current year+8.23%
1 week 0.76
Extreme 0.76
0.86
1 month 0.7
Extreme 0.7
0.9
Current year 0.7
Extreme 0.7
1.16
1 year 0.52
Extreme 0.515
1.16
3 years 0.34
Extreme 0.337
1.17
5 years 0.34
Extreme 0.337
1.8
10 years 0.34
Extreme 0.337
3.31
Manager TitleAgeSince
Chief Executive Officer - 11/11/2014
Director of Finance/CFO - 06/05/2021
Chief Operating Officer - 03/02/2011
Director TitleAgeSince
Director/Board Member - 11/11/2014
Chairman - 21/09/2017
Director/Board Member - 01/02/2017
Date Insider Type Main position Quantity % Market Cap.
18/11/25 Sell

Chief Executive Officer

255,199 0.1528%
18/11/25 Buy

Chief Executive Officer

529,638 0.3171%
6/11/25 Buy

Chief Financial Officer

2,447 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
+0.59%+13.25%+56.88%-28.15% 99.15M
+1.64%+1.74%+33.88%+82.16% 13.23B
-4.30%-1.16%-31.43%+247.99% 7.86B
+1.21%+8.06%-13.20%-51.38% 2.49B
-8.34%-2.55% - - 1.42B
+1.08%-2.88%-79.18%-66.14% 1.41B
-2.95%+8.11%-24.57%-20.04% 1.33B
+0.33%+0.67%+20.88%+47.58% 1.24B
-3.07%-8.82%+29.34%-11.12% 1.24B
-8.20%-13.23%-66.15%-70.73% 980M
Average -2.20%+0.51%-8.17%+14.46% 3.13B
Weighted average by Cap. -1.11%+2.01%+0.91%+92.41%

Financials

2026 *2027 *
Net sales 94M 65.64M 57.36M 52.93M 48.79M 91.96M 6.32B 633M 249M 3.1B 247M 241M 10.66B 116M 81.07M 70.85M 65.38M 60.26M 114M 7.81B 781M 307M 3.82B 304M 298M 13.16B
Net income 9.8M 6.84M 5.98M 5.52M 5.09M 9.59M 659M 65.96M 25.94M 323M 25.7M 25.14M 1.11B 13.5M 9.43M 8.24M 7.6M 7.01M 13.21M 908M 90.86M 35.74M 445M 35.4M 34.63M 1.53B
Net Debt -2.3M -1.61M -1.4M -1.3M -1.19M -2.25M -155M -15.48M -6.09M -75.75M -6.03M -5.9M -261M -7.2M -5.03M -4.39M -4.05M -3.74M -7.04M -484M -48.46M -19.06M -237M -18.88M -18.47M -816M
Logo Clover Corporation Limited
Clover Corporation Limited focused on technology, new product development, and commercialization. The principal activities of the Company are the refining and sale of natural oils, the production of encapsulated powders and the research and product development of functional food and infant nutrition ingredients. Its microencapsulation technology enables nutritional oils, such as tuna, fish, algal and fungal oils, to be added to infant formulas, foods, and beverages. Its technologies protect those sensitive oils from oxidation, allowing them to be incorporated into a range of applications. The Company, through its subsidiary, Nu-Mega Ingredients Pty Limited (Nu-Mega), supplies refined Omega-3 oils and a range of other encapsulated ingredients for use in infant formula, nutraceuticals, pharmaceuticals, and sports nutrition markets. Nu-Mega’s Driphorm range of microencapsulated powders enables the addition of Hi-DHA tuna and/or algal oils to a broad spectrum of products.
Employees
68
Date Price Change Volume
17/07/26 $0.8550 +0.59% 17,257
16/07/26 $0.8500 +0.59% 48,735
15/07/26 $0.8450 +7.64% 88,714
14/07/26 $0.7850 +0.64% 40,268
13/07/26 $0.7800 +3.31% 34,306
Trader
-
Investor
Global
-
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.8550AUD
Average target price
1.280AUD
Spread / Average Target
+49.71%

Annual profits - Rate of surprise